Wearable Devices Secures $750,000 Grant for Clinical Pilot Program
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 11 2025
0mins
Should l Buy WLDS?
Source: Newsfilter
- Funding Support: Wearable Devices has received a $750,000 grant approval from the Israel Innovation Authority for a clinical pilot program in partnership with Soroka University Medical Center, aimed at validating the Mudra Link neural wristband as a rehabilitation tool, thereby expanding the company's market presence in medical technology.
- Technology Application: The pilot will utilize patented surface neural ElectroMyography (EMG) technology to provide real-time, objective biofeedback to help patients improve grip-force control, marking a broader applicability of Mudra technology in neural interaction and enhancing the competitiveness of the company's products.
- Market Potential: The Mudra platform is designed for low-cost rehabilitation therapy that can be performed at home with minimal therapist supervision, which not only meets the demand for efficient rehabilitation solutions but also positions it to potentially establish itself as the standard of care in grip-force neurorehabilitation worldwide.
- Clinical Validation: By collaborating with Soroka Hospital, Wearable Devices is advancing clinical validation, aiming to leverage Mudra Link's ability to capture objective neuro-muscular data, thus enhancing treatment accessibility and accelerating recovery for patients with complex neurological motor deficits.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WLDS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WLDS
About WLDS
Wearable Devices Ltd is an Israel-based company. Wearable Devices Ltd is primarily engaged in developing a non-invasive neural input interface technology for business-to-business (B2B) and business-to-customer (B2C) customers. Company's products are non-invasive neural input interface closed in the form of a wristband to allow control of other digital devices with natural subtle hand finger movements and fingertip pressure. Company's technology is used in digital devices such as, consumer electronics, smart watches, smartphones, Augmented Reality (AR) glasses, Virtual Reality (VR) headsets, televisions, personal computers (PCs), laptop , drones, robots. Company's product portfolio includes Mudra Band and Mudra Inspire.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wearable Devices Enters Warrant Inducement Agreement
- Financing Agreement Reached: Wearable Devices has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of 2,904,499 existing warrants at an exercise price of $1.73 per share, expected to raise approximately $5 million in cash, enhancing the company's working capital and operational capacity.
- New Warrants Issued: As part of the transaction, the investor will receive 5,082,873 new warrants with an exercise price of $1.51 per share, which are immediately exercisable and will expire in five years, further improving the company's capital structure and financing flexibility.
- Transaction Timeline: The warrant inducement transaction is expected to close on April 21, 2026, subject to customary closing conditions, demonstrating the company's activity in the capital markets and confidence in future growth.
- Market Compliance: This transaction relies on an exemption under Section 4(a)(2) of the Securities Act of 1933, ensuring compliance for the newly issued securities in the U.S. market, reflecting the company's commitment to legal regulations and its compliant operations in the capital markets.
See More
Lucid and Others Hit 52-Week Lows Amid Financing Concerns
- Lucid Stock Decline: Lucid's shares fell over 7.5% on Monday, extending a five-day decline to a 52-week low of $6.75, primarily driven by financing decisions and the appointment of a new CEO, reflecting market uncertainty about the company's future.
- Financing Concerns Intensify: Last week, Lucid announced a $1.05 billion capital raise, including a $300 million registered offering of common stock; despite Uber increasing its stake in Lucid to 11.5%, analysts lowered price targets, with TD Cowen cutting it from $19 to $10 and Baird from $14 to $12.
- Aspire Biopharma Financing Issues: Aspire Biopharma's stock declined for four consecutive days, hitting a low of $0.22 on Monday after announcing the closure of a $21 million private placement and securing an additional $22.5 million credit line for acquiring Dura Control Systems, indicating significant financing pressure.
- Wearable Devices Stock Drop: Wearable Devices' shares fell to $1.10 on Monday after entering a $5 million warrant inducement agreement, intended for working capital; however, the company failed to alleviate investor concerns regarding dilution and funding needs.
See More
Wearable Devices Partners with Meta-Bounds for AR Integration
- Clear Partnership Goals: Wearable Devices' collaboration with Meta-Bounds aims to integrate its Mudra Band and Mudra Link products for spatial interaction, focusing on end consumers in the short term and enterprise users in the long term, demonstrating the company's deep understanding of market demands.
- Significant Stock Surge: Following the announcement of the partnership with Meta-Bounds, Wearable Devices' shares surged nearly 115% on Monday, marking the best intraday gain in over seven months, reflecting strong market optimism regarding its AR control technology.
- Product Development Plans: In the short term, Wearable Devices plans to develop preliminary wristband controllers that allow users to control their AR experience through gestures, enhancing user interaction and promoting the adoption of AR technology.
- Expansive Market Outlook: According to a report by Fortune Business Insights, the global AR market is projected to grow to $2.3 trillion by 2034, positioning Wearable Devices strategically to capitalize on this rapidly expanding market.
See More
Wearable Devices Reports FY 2025 Financial Results
- Financial Highlights: Wearable Devices reported a GAAP EPS of -$6.53 for FY 2025 with revenues of $0.65 million, indicating significant challenges in profitability that could impact investor confidence.
- Cash Position: As of December 31, 2025, the company reported cash and deposits of $18.4 million, a substantial increase from $4.0 million at the end of 2024, primarily due to approximately $24.4 million raised in 2025, enhancing financial stability.
- Sales and Marketing Expenses: Sales and marketing expenses decreased by 12% to $1.85 million for FY 2025, reflecting adjustments in the sales and marketing structure, although overall spending still needs attention to enhance market competitiveness.
- Stable Administrative Costs: General and administrative expenses remained steady at $2.8 million for FY 2025, unchanged from FY 2024, indicating efforts to control management costs, but further optimization is necessary to improve overall profitability.
See More
Wearable Devices Announces One-for-Three Reverse Stock Split
- Reverse Stock Split Announcement: Wearable Devices has announced a one-for-three reverse stock split aimed at increasing the per-share trading price to meet Nasdaq's minimum bid requirement of $1.00, thereby maintaining its listing status.
- Impact on Shares: The reverse split will reduce the number of issued ordinary shares from 10,593,227 to approximately 3,531,076, while the number of publicly held warrants will decrease from 98,589 to about 32,863, significantly lowering the float.
- Trading Symbols Unchanged: Post-split, the company's ordinary shares and warrants will continue to trade on the Nasdaq under the existing symbols “WLDS” and “WLDSW,” ensuring convenience for investors.
- Market Reaction: Following the announcement of the reverse split, Wearable Devices' stock price fell by 5.92% in after-hours trading to $0.7452, indicating market caution regarding the split plan.
See More
Wearable Devices Implements Reverse Split to Maintain Nasdaq Listing Compliance
- Reverse Split Announcement: Wearable Devices plans a 1-for-3 reverse stock split to increase the per-share trading price and comply with Nasdaq's $1.00 minimum bid requirement, thereby protecting its listing status and avoiding immediate delisting risks.
- Shareholder Approval: The reverse split was approved at the Special General Meeting on February 19, 2026, demonstrating the company's commitment to compliance and proactive management of its listing status.
- Impact on Shares: Following the reverse split, the number of outstanding shares will decrease from 10,593,227 to approximately 3,531,076, and publicly held warrants will reduce from 98,589 to about 32,863, ensuring that shareholder interests remain largely unaffected.
- Market Trading Arrangements: The reverse split will take effect on March 11, 2026, with ordinary shares and warrants continuing to trade under existing symbols on Nasdaq, ensuring investor trading convenience and market liquidity.
See More
Wearable Devices Enters Warrant Inducement Agreement
- Financing Agreement Reached: Wearable Devices has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of 2,904,499 existing warrants at an exercise price of $1.73 per share, expected to raise approximately $5 million in cash, enhancing the company's working capital and operational capacity.
- New Warrants Issued: As part of the transaction, the investor will receive 5,082,873 new warrants with an exercise price of $1.51 per share, which are immediately exercisable and will expire in five years, further improving the company's capital structure and financing flexibility.
- Transaction Timeline: The warrant inducement transaction is expected to close on April 21, 2026, subject to customary closing conditions, demonstrating the company's activity in the capital markets and confidence in future growth.
- Market Compliance: This transaction relies on an exemption under Section 4(a)(2) of the Securities Act of 1933, ensuring compliance for the newly issued securities in the U.S. market, reflecting the company's commitment to legal regulations and its compliant operations in the capital markets.
See More
Lucid and Others Hit 52-Week Lows Amid Financing Concerns
- Lucid Stock Decline: Lucid's shares fell over 7.5% on Monday, extending a five-day decline to a 52-week low of $6.75, primarily driven by financing decisions and the appointment of a new CEO, reflecting market uncertainty about the company's future.
- Financing Concerns Intensify: Last week, Lucid announced a $1.05 billion capital raise, including a $300 million registered offering of common stock; despite Uber increasing its stake in Lucid to 11.5%, analysts lowered price targets, with TD Cowen cutting it from $19 to $10 and Baird from $14 to $12.
- Aspire Biopharma Financing Issues: Aspire Biopharma's stock declined for four consecutive days, hitting a low of $0.22 on Monday after announcing the closure of a $21 million private placement and securing an additional $22.5 million credit line for acquiring Dura Control Systems, indicating significant financing pressure.
- Wearable Devices Stock Drop: Wearable Devices' shares fell to $1.10 on Monday after entering a $5 million warrant inducement agreement, intended for working capital; however, the company failed to alleviate investor concerns regarding dilution and funding needs.
See More
Wearable Devices Partners with Meta-Bounds for AR Integration
- Clear Partnership Goals: Wearable Devices' collaboration with Meta-Bounds aims to integrate its Mudra Band and Mudra Link products for spatial interaction, focusing on end consumers in the short term and enterprise users in the long term, demonstrating the company's deep understanding of market demands.
- Significant Stock Surge: Following the announcement of the partnership with Meta-Bounds, Wearable Devices' shares surged nearly 115% on Monday, marking the best intraday gain in over seven months, reflecting strong market optimism regarding its AR control technology.
- Product Development Plans: In the short term, Wearable Devices plans to develop preliminary wristband controllers that allow users to control their AR experience through gestures, enhancing user interaction and promoting the adoption of AR technology.
- Expansive Market Outlook: According to a report by Fortune Business Insights, the global AR market is projected to grow to $2.3 trillion by 2034, positioning Wearable Devices strategically to capitalize on this rapidly expanding market.
See More
Wearable Devices Reports FY 2025 Financial Results
- Financial Highlights: Wearable Devices reported a GAAP EPS of -$6.53 for FY 2025 with revenues of $0.65 million, indicating significant challenges in profitability that could impact investor confidence.
- Cash Position: As of December 31, 2025, the company reported cash and deposits of $18.4 million, a substantial increase from $4.0 million at the end of 2024, primarily due to approximately $24.4 million raised in 2025, enhancing financial stability.
- Sales and Marketing Expenses: Sales and marketing expenses decreased by 12% to $1.85 million for FY 2025, reflecting adjustments in the sales and marketing structure, although overall spending still needs attention to enhance market competitiveness.
- Stable Administrative Costs: General and administrative expenses remained steady at $2.8 million for FY 2025, unchanged from FY 2024, indicating efforts to control management costs, but further optimization is necessary to improve overall profitability.
See More
Wearable Devices Announces One-for-Three Reverse Stock Split
- Reverse Stock Split Announcement: Wearable Devices has announced a one-for-three reverse stock split aimed at increasing the per-share trading price to meet Nasdaq's minimum bid requirement of $1.00, thereby maintaining its listing status.
- Impact on Shares: The reverse split will reduce the number of issued ordinary shares from 10,593,227 to approximately 3,531,076, while the number of publicly held warrants will decrease from 98,589 to about 32,863, significantly lowering the float.
- Trading Symbols Unchanged: Post-split, the company's ordinary shares and warrants will continue to trade on the Nasdaq under the existing symbols “WLDS” and “WLDSW,” ensuring convenience for investors.
- Market Reaction: Following the announcement of the reverse split, Wearable Devices' stock price fell by 5.92% in after-hours trading to $0.7452, indicating market caution regarding the split plan.
See More
Wearable Devices Implements Reverse Split to Maintain Nasdaq Listing Compliance
- Reverse Split Announcement: Wearable Devices plans a 1-for-3 reverse stock split to increase the per-share trading price and comply with Nasdaq's $1.00 minimum bid requirement, thereby protecting its listing status and avoiding immediate delisting risks.
- Shareholder Approval: The reverse split was approved at the Special General Meeting on February 19, 2026, demonstrating the company's commitment to compliance and proactive management of its listing status.
- Impact on Shares: Following the reverse split, the number of outstanding shares will decrease from 10,593,227 to approximately 3,531,076, and publicly held warrants will reduce from 98,589 to about 32,863, ensuring that shareholder interests remain largely unaffected.
- Market Trading Arrangements: The reverse split will take effect on March 11, 2026, with ordinary shares and warrants continuing to trade under existing symbols on Nasdaq, ensuring investor trading convenience and market liquidity.
See More
